CTRI/2023/10/058621
Not Yet Recruiting
Phase 2
Accelerated Hypofractionated Palliative Radiotherapy Vs Standard Hypofractionated Palliative Radiotherapy With Concurrent Chemotherapy In Locally Advanced Head And Neck Carcinoma: A Randomised Controlled Study - nil
AIIMS, New Delhi0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- AIIMS, New Delhi
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Treatment naive, Histo\-pathologically proven Squamous Cell Carcinoma of head and neck region excluding nasopharyngeal, para\-nasal sinus and salivary gland primary
- •\-Defined as incurable or palliative intent by Head and Neck multidisciplinary team (MDT)
- •\-Adequate organ functions and bone marrow reserve
- •\-Eastern Co\-operative Oncology Group Performance Score (ECOG PS)\- (0\-3\)
- •\-Age: 18\- 70 years
- •\-Negative viral serology markers (HIV, HBsAg, HCV)
- •\-Giving written Informed consent
Exclusion Criteria
- •\-Nasopharyngeal, para\-nasal sinus or salivary gland primary
- •\-Recurrent disease
- •\-Metastatic disease
- •\-Patients who have previously received oncologic treatment with surgery, radiotherapy or chemotherapy
- •\-Pregnant patients
- •\-Synchronous malignancy or any other malignancy with in last 5 years
- •\-Known uncontrolled medical comorbidities which could impact QOL
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in adenocarcinoma of the esophagus or esophogastric junction trial - a phase II clinical trial protocol.EUCTR2014-002362-74-SESkåne University Hospital, Department of Oncology
Completed
N/A
Quality of Life After Conformal Radiotherapy in Late Stage Oral Cavity Cancer:A Prospective clinical TrialCTRI/2018/03/012441Jawaharlal Institue of Postgraduate Medical Education and research25
Completed
Phase 2
Intensity-modulated, hypofractionated radiotherapy with scanning beam protons for locally advanced carcinoma of the prostate and localized carcinoma of the prostate with risk factors - a phase II studyC61Malignant neoplasm of prostateDRKS00011912Westdeutsches Protonentherapiezentrum Essen (WPE)133
Completed
Phase 1
Hypofractionated radiotherapy for low and intermediate-risk prostate cancer using robot-tracking stereotactic radiotherapy -phase I/II clinical trialprostate cancerJPRN-UMIN000014328Osaka University Graduate School of Medicine75
Recruiting
Phase 3
Standard moderately hypofractionated radiotherapy vs. ultra-hypofractionated focal lesion ablative microboost in prostate cancer, Hypo-FLAME 3.0prostate cancer10038597NL-OMON56327Antoni van Leeuwenhoek Ziekenhuis352